CAPSULES & LIQUID
Infliximab: understanding TNF-targeted treatment
Dr. Purser’s teaching
WHAT YOU’LL LEARN
Understand the connection
Infliximab, sold as Remicade and as biosimilars, is a prescribed antibody medicine that targets TNF-alpha. It is used for selected inflammatory conditions.
Follow the pathway
Dr. Purser explains soluble and membrane-bound TNF-alpha, infusion treatment, and why effectiveness can differ between people. He discusses loss of response, antibodies to the medicine, and the importance of distinguishing an appropriate target from an unconfirmed genetic interpretation.
Bring these questions to your visit
Ask about infection screening, infusion reactions, monitoring, and whether other medicines change the safety picture. Discuss what would count as an adequate response and the next steps if symptoms return.
Keep exploringFind related teaching
EXPLORE WITH YOUR CARE TEAM
Supplements to explore
Compare the products below, including their ingredients and available forms. Your care team can help you choose one or more options for your needs.
Dr. Purser discusses these supplements in relation to TNF.
Some genetic results may make these options more relevant to you. Review your full genetic report with your clinician before choosing a supplement.
See more supplement options
SUPPLEMENT OPTIONS
VARS SOD
SUPPLEMENT OPTIONS
TNF supplement options
SUPPLEMENT OPTIONS
VARS Catalase Support
COMPARE YOUR OPTIONS
Methylation support
Explore supplements Dr. Purser discusses alongside inflammation and antioxidant support.
MTHFR Daily and Hydroxy B12 + Folinic Acid are alternatives. Your results can help your clinician choose between them.
Tell your care team which supplements and medicines you already take. Check the product page for current ingredients, prices, and availability.
YOUR LEARNING
